• Clinical Trials - Multiple myeloma

    Study Objective Contact
    Detection of Contaminating Tumor Cells in Autologous Peripheral Blood Progenitor Cell Grafts and Monitoring of Relapse in Multiple Myeloma Patients Using Molecular and Immunophenotyping Techniques [LCID Study Number: 2003-034] A study of a new molecular method to detect early relapse after stem cell transplant in multiple myeloma patients. Principal Investigator(s):
    Gyorgy Abel, MD, PhD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Gyorgy Abel, MD, PhD.
    S1304: A Phase II Randomized Study Comparing Two Doses of Carfilzomib (nsc-756640) with Dexamethasone for Multiple Myeloma Patients with Relapsing or Refractory Disease [LCID Study Number: 2014-007] This study aims to evaluate and compare progression free survival of two different doses of carfilzomib with dexamethasone in multiple myeloma patients with relapsed and/or disease that has not responded to treatment. Principal Investigator(s):
    Tarun Kewalramani, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Deborah J. Gannon.